The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index; 2 of the 2 sources its claims cite were checked for support.
Matrix stiffness modulates hepatic stellate cell activation into tumor-promoting myofibroblasts via E2F3-dependent signaling and regulates malignant progression
Open accessAbstract
The hepatic stellate cells (HSCs) activation by myofibroblastic differentiation is critical for liver fibrosis. Crosstalk between stromal cells and tumor cells in the microenvironment alters the properties and facilitates the growth and metastasis of tumor cells. How mechanical stimuli originally stiffness of extracellular matrix (ECM) contribute to tumor development remains poorly understood. Here, we demonstrated that stiffness contributes to mechanosignal transduction in HSCs, which promotes hepatocellular carcinoma (HCC) cells growth and metastasis through secretion of FGF2. On stiffness matrix, HSCs activation was confirmed by immunofluorescence (IF) and Western blot (WB) for α-smooth muscle actin (SMA). Increasing matrix stiffness promoted HSCs activation by CD36-AKT-E2F3 mechanosignaling through shRNA-mediated E2F3 knockdown, AKT inhibitors, and CD36 shRNA. Moreover, ChIP-qPCR. Confirmed that E2F3 combined the promoter of FGF2, and stiffness promoted FGF2 expression. On a stiff matrix, HCC cells cultured with conditioned media (CM) from HSCs increased HCC cells growth and metastasis by binding FGFR1 to activate PI3K/AKT and MEK/ERK signaling pathways. Moreover, conditional E2F3 knockout mice were subjected to CCl4 treatment to assess the role of E2F3 in HSC activation. Additionally, the DEN-induced HCC model was also used to evaluate the role of E2F3 in liver fibrosis and HCC growth. In conclusion, we demonstrated that stiffness-induced HSC activation by E2F3 dependent. Stiffness activated CD36-AKT-E2F3 signaling and targeted FGF2 transcription, subsequently, activated HCC growth and metastasis by FGFR1-mediated PI3K/AKT and MEK/ERK signaling.
Overview
CoChat Summary
TL;DR
This study argues that a stiff extracellular matrix drives hepatic stellate cell (HSC) activation into tumor-promoting myofibroblasts through a CD36-AKT-E2F3 pathway. Activated HSCs then secrete FGF2, which promotes hepatocellular carcinoma (HCC) growth and metastasis in vitro and in mice.
Key findings
- On 32 kPa hydrogels, HSCs showed activated/myofibroblastic features, including elongated morphology and increased α-SMA; E2F3 and CTGF also increased, while 1 kPa soft gels showed a round morphology.
- E2F3 knockdown abolished stiffness-induced HSC activation: stiffness-induced increases in α-SMA and CTGF were suppressed in human HSCs and LX2 cells, with effects reported as significant at P < 0.05.
- CD36 was required for the stiffness response: the CD36 inhibitor SSO blocked stiffness-induced α-SMA and E2F3 upregulation, and CD36 overexpression on 1 kPa mimicked 32 kPa stiffness.
- Stiffness induced E2F3-dependent FGF2 transcription and secretion: E2F3 increased FGF2 promoter activity sixfold, and CM from 32 kPa HSCs promoted Hep3B proliferation and migration; in the mouse co-injection model, 32 kPa CM increased tumor growth by day 10, while E2F3 knockdown in HSCs abolished this effect.
- In vivo, conditional E2F3 knockout reduced CCl4-induced HSC activation/liver fibrosis, and E2F3 +/+ cre mice developed macroscopic tumors compared with E2F3 F/F cre mice in the DEN model.
Methods
- In vitro design: primary human HSCs, LX2 cells, and Hep3B cells were cultured on polyacrylamide hydrogels of different stiffness, especially 1 kPa and 32 kPa.
- Mechanistic assays included Western blotting, immunofluorescence/confocal microscopy, qRT-PCR, ELISA for FGF2, ChIP-qPCR, reporter assays, co-IP, CCK8 proliferation, and Transwell migration.
- In vivo studies included subcutaneous co-injection of Hep3B cells with HSC conditioned media into SCID mice, plus CCl4-induced fibrosis in mice and a DEN-based HCC/fibrosis model with conditional E2F3 knockout.
Limitations
- The paper does not state explicit limitations.
- Evident from the text: several key claims rely on cell-line and mouse-model systems, so direct human causal evidence is limited in the provided text.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures








Verification
Claims the paper makes
2 Valid · 0 Not valid · 0 Not checked · 55 Own results and interpretations
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“we performed WB to confirm that AKT phosphorylation was intermediate according to previous studies (P < 0.05 by t-test, Fig. 4A) [19].”
§ Matrix stiffness modulates hepatic stellate cell activation into tumor-promoting myofibroblasts via E2F3-dependent signaling and regulates malignant progression > Results > Stiffness promoted E2F3 expression by activating a CD36-AKT pathway
What the sources say
- Partly supportedcites [19] Rios FJ, Koga MM, Ferracini M, Jancar S. Co-stimulation of PAFR and CD36 is required for oxLDL-induced human macrophages activation. PLoS ONE. 2012;7:e36632. sourceExperimental — accuracy not yet measured
The Results section (page unavailable) reports that oxLDL induces Akt phosphorylation in human macrophages, and the Discussion places PI3K/Akt upstream of p38 and JNK activation. That supports Akt phosphorylation as part of an intermediate signaling pathway, but the paper studies oxLDL stimulation, not stiffness-induced signaling. (LLM, conf=0.85)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Rests on an assumption not shown here.
- Partly supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“Stiffness promoted transcription of more than 20 tumor-promoting factors, including FGF, CTGF, and IL6 [12].”
§ Matrix stiffness modulates hepatic stellate cell activation into tumor-promoting myofibroblasts via E2F3-dependent signaling and regulates malignant progression > Results > Stiffness-E2F3 axis promotes transcription of tumor-promoting factors of HSCs
What the sources say
- Supportedcites [12] Dou C, Liu Z, Tu K, Zhang H, Chen C, Yaqoob U, et al. P300 acetyltransferase mediates stiffness-induced activation of hepatic stellate cells into tumor-promoting myofibroblasts. Gastroenterology 2018;154:2209–21. e14 source
The Results section (“Stiffness-p300 axis epigenetically turns on transcription of tumor-promoting factors of HSCs,” Fig. 5C) states that stiffness promoted transcription of more than 20 tumor-promoting factors and explicitly includes FGF, CTGF, and IL6. (LLM, conf=0.95)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Rests on an assumption not shown here.
- Supported
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“In addition, we used CCl4 to induce liver fibrosis and found that E2F3 was increased in CCl4-induced liver, moreover, CCl4-mediated HSC activation was reduced in E2F3 F/F cre livers (P < 0.05 by t-test, Fig. 8).”
- Also stated in: § E2F3 is overexpressed in the HSCs/MF murine and the patient’s HCC and CCl4-induced fibrosis was reversed in conditional E2F3 knockout mice · plain
“moreover, CCl4-mediated HSC activation was reduced in E2F3 F/F cre livers (P < 0.05 by t-test, Fig. 8).”
§ Matrix stiffness modulates hepatic stellate cell activation into tumor-promoting myofibroblasts via E2F3-dependent signaling and regulates malignant progression > Results > E2F3 is overexpressed in the HSCs/MF murine and the patient’s HCC and CCl4-induced fibrosis was reversed in conditional E2F3 knockout mice
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Rests on an assumption not shown here.
- Also stated in: § E2F3 is overexpressed in the HSCs/MF murine and the patient’s HCC and CCl4-induced fibrosis was reversed in conditional E2F3 knockout mice · plain
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“We performed qRT-PCR and WB and found that CD36 mRNA and protein level all increased in primary human HSCs and LX2 cells (P < 0.05 by t-test, Fig. 3A, B).”
§ Matrix stiffness modulates hepatic stellate cell activation into tumor-promoting myofibroblasts via E2F3-dependent signaling and regulates malignant progression > Results > Stiffness promoted E2F3 expression is mediated by CD36
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Rests on an assumption not shown here.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“WB confirmed that stiffness-mediated HSC activation was inhibited in E2F3 knockdown LX2 cells (P < 0.05 by ANOVA Fig. 2C).”
§ Matrix stiffness modulates hepatic stellate cell activation into tumor-promoting myofibroblasts via E2F3-dependent signaling and regulates malignant progression > Results > E2F3 knockdown abolished the matrix stiffness-induced HSCs activation
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Rests on an assumption not shown here.
41 more claims
Create a free account to see all 57 claims and every source verdict.
- It may state two separate claims as one. 11
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Self-check results appear here once an independent check has confirmed them.
Cited works that were retracted
Works this paper cites that were later retracted, from the retraction notices publishers deposit. Major when the notice came out before this paper was published.
A note, not an issue: for example, a cited work that was retracted only after this paper was published, which its authors could not have known.
In the paper
“Liu Z, Wang Y, Wang L, Yao B, Sun L, Liu R, et al. Long non-coding RNA AGAP2-AS1, functioning as a competitive endogenous RNA, upregulates ANXA11 expression by sponging miR-16-5p and promotes proliferation and metastasis in hepatocellular carcinoma. J Exp Clin cancer Res: CR. 2019;38:194.”
Cited work 10.1186/s13046-019-1188-x · retracted 2022-11-02 · notice 10.1186/s13046-022-02521-z · this paper published 2021-12-06
A note, not an issue: for example, a cited work that was retracted only after this paper was published, which its authors could not have known.
In the paper
“Liu Z, Dou C, Yao B, Xu M, Ding L, Wang Y, et al. Ftx non coding RNA-derived miR-545 promotes cell proliferation by targeting RIG-I in hepatocellular carcinoma. Oncotarget 2016;7:25350–65.”
Cited work 10.18632/oncotarget.8129 · retracted 2025-02-18 · notice 10.18632/oncotarget.28695 · this paper published 2021-12-06
Citations
Cites
2 retracted
Liu, Z., Wang, Y., Wang, L., Yao, B., Sun, L., Liu, R., Chen, T., Niu, Y., Tu, K., & Liu, Q. (2019) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-019-1188-x · Cited by 136
Self-citationRetractedLiu, Z., Dou, C., Yao, B., Xu, M. M., Ding, L., Wang, Y., Jia, Y., Li, Q., Zhang, H., Tu, K., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.8129 · Cited by 124
Self-citationRetractedSiegel, R., Naishadham, D., & Jemal, A. (2012) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.20138 · Cited by 10,679
Accessories to the Crime: Functions of Cells Recruited to the Tumor Microenvironment
Hanahan, D., & Coussens, L. M. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.02.022 · Cited by 4,632 · cited 1×
“RESULTS Increasing matrix stiffness-induced MF activation of HSCs and promoted the expression of E2F3 in human HSCs and LX2 cells Pathological fibrosis is driven by a feedback loop in which the fibrotic extracellular matrix is both cause and consequence of fibroblast activation [17].”
BackgroundEffects of substrate stiffness on cell morphology, cytoskeletal structure, and adhesion
Yeung, T., Georges, P. C., Flanagan, L. A., Marg, B., Ortiz, M., Funaki, M., Zahir, N., Ming, W., Weaver, V., & Janmey, P. A. (2005) · Cell Motility and the Cytoskeleton · doi:10.1002/cm.20041 · Cited by 2,325 · cited 3×
“The cancerassociated fibroblasts (CAFs) are responsible for the remodeling of ECM and subsequent growth and dissemination of tumor cells [24].”
BackgroundFibroblast Adaptation and Stiffness Matching to Soft Elastic Substrates
Solon, J., Levental, I., Sengupta, K., Georges, P. C., & Janmey, P. A. (2007) · Biophysical Journal · doi:10.1529/biophysj.106.101386 · Cited by 1,027 · cited 8×
“On the contrary, ECM-mediated stiffness promotes malignancies by modulating cell growth, motility, proliferation, metabolism, and metastasis, such as clustering of integrin-based adhesion proteins into focal adhesions, Rho-ROCK activation, and nuclear localization of transcriptional regulators YAP and SNAIL1 [5].”
BackgroundInfluentialSchrader, J., Gordon-Walker, T. T., Aucott, R. L., van Deemter, M., Quaas, A., Walsh, S., Benten, D., Forbes, S. J., Wells, R. G., & Iredale, J. P. (2011) · Hepatology · doi:10.1002/hep.24108 · Cited by 720 · cited 1×
“Activated HSCs in the liver microenvironment regulate HCC growth by paracrine mechanisms, including secreting growth factors, ECM, cytokines [6, 7].”
BackgroundThe E2F transcriptional network: old acquaintances with new faces
Dimova, D. K., & Dyson, N. J. (2005) · Oncogene · doi:10.1038/sj.onc.1208612 · Cited by 715 · cited 1×
“E2F3, as a member of the E2F family, was originally identified as an E2F1 paralog through low-stringency hybridization experiments [11].”
BackgroundThe E2F family: specific functions and overlapping interests
Attwooll, C., Denchi, E. L., & Helin, K. (2004) · The EMBO Journal · doi:10.1038/sj.emboj.7600481 · Cited by 573
Fibrosis-dependent mechanisms of hepatocarcinogenesis
Zhang, D. Y., & Friedman, S. L. (2012) · Hepatology · doi:10.1002/hep.25670 · Cited by 444 · cited 1×
“Activated HSCs in the liver microenvironment regulate HCC growth by paracrine mechanisms, including secreting growth factors, ECM, cytokines [6, 7].”
Background
Cited by
Sleeboom, J. J. F., van Tienderen, G. S., Schenke-Layland, K., van der Laan, L. J. W., Khalil, A. A., & Verstegen, M. M. A. (2024) · Science Translational Medicine · doi:10.1126/scitranslmed.adg3840 · Cited by 375
“Furthermore, in HCC, CAFs originating from hepatic stellate cells are activated by stiffened ECM and promote invasion by secreting fibroblast growth factor 2 ( 51 ).”
BackgroundImmune microenvironment in hepatocellular carcinoma: from pathogenesis to immunotherapy
Seyhan, D., Allaire, M., Fu, Y., Conti, F., Wang, X. W., Gao, B., & Lafdil, F. (2025) · Cellular and Molecular Immunology · doi:10.1038/s41423-025-01308-4 · Cited by 162
“To further under-score this confounding effect, another study revealed that this stiffness phenotype also activated HSCs and led to HCC progression [61].”
Advances of cancer-associated fibroblasts in liver cancer
Peng, H., Zhu, E., & Zhang, Y. (2022) · Biomarker Research · doi:10.1186/s40364-022-00406-z · Cited by 86
“A recent study showed that stiffness induced HSCs activation through the CD36AKT-E2F3 mechano-signaling pathway, which in turn promoted FGF2 transcription and secretion to promote HCC growth and distant metastasis [121].”
BackgroundExosomes-regulated lipid metabolism in tumorigenesis and cancer progression
Ye, L., Li, Y., Zhang, S., Wang, J., & Lei, B. (2023) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2023.05.002 · Cited by 58
Cellular mechanosignaling for sensing and transducing matrix rigidity
Young, K. M., & Reinhart‐King, C. A. (2023) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2023.102208 · Cited by 52
Metadata
- Authors
- Liu, Z., Mo, H., Liu, R., Niu, Y., Chen, T., Xu, Q., Tu, K., & Yang, N.
- Affiliations
- First Affiliated Hospital of Xi'an Jiaotong University (CN)
- Zhejiang Provincial People's Hospital (CN)
- Corresponding author
- Tu, Kangsheng
- Yang, Nan
- Venue
- Cell Death & Disease
- Published
- 2021-12-06
- Volume
- 12
- Issue
- 12
- Pages
- 1134-1134
- ISSN
- 2041-4889 (ISSN-L)
- PMC
- PMC8648844
- OpenAlex
- W4200090961
- Cited by
- 67
- References
- 27
- Citations by year
- 2026: 7 · 2025: 14 · 2024: 18 · 2023: 21 · 2022: 7
- FWCI
- 6.39
- Type
- journal article
- Language
- en
- Update notices
- correction (2022-01-28)
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- Cell Death and Disease (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Fundamental Research Funds for the Central Universities
- Topics
- Health Sciences › Medicine › Hepatology › Liver physiology and pathology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Cellular Mechanics and Interactions
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › TGF-β signaling in diseases
- Keywords
- hepatic stellate cell activation, extracellular matrix stiffness, mechanotransduction, E2F3, CD36, Akt signaling, FGF2, FGFR1, hepatocellular carcinoma, metastasis, liver fibrosis, PI3K/Akt signaling, MEK/ERK signaling, tumor microenvironment
- MeSH terms
- Animals, Carcinoma, Hepatocellular, Liver Cirrhosis, Liver Neoplasms, Fibroblast Growth Factor 2, Phosphatidylinositol 3-Kinases, Mitogen-Activated Protein Kinase Kinases, RNA, Small Interfering, Cell Proliferation, E2F3 Transcription Factor, Proto-Oncogene Proteins c-akt, Mice, Hepatic Stellate Cells, Myofibroblasts, Tumor Microenvironment
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Matrix stiffness modulates hepatic stellate cell activation into tumor-promoting myofibroblasts via E2F3-dependent signaling and regulates malignant progression. https://app.cochat.ai/papers/10.1038/s41419-021-04418-9
- The paper
- Liu, Z., Mo, H., Liu, R., Niu, Y., Chen, T., Xu, Q., Tu, K., & Yang, N. (2021). Matrix stiffness modulates hepatic stellate cell activation into tumor-promoting myofibroblasts via E2F3-dependent signaling and regulates malignant progression. Cell Death & Disease. https://doi.org/10.1038/s41419-021-04418-9
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.